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Abstract
The genetic programs underlying neural stem cell (NSC) proliferation and pluripotentiality have only been partially elucidated. We
compared the gene expression profile of proliferating neural stem cell cultures (NS) with cultures differentiated for 24 h (DC) to identify
functionally coordinated alterations in gene expression associated with neural progenitor proliferation. The majority of differentially
expressed genes (65%) were upregulated in NS relative to DC. Microarray analysis of this in vitro system was followed by high throughput
screening in situ hybridization to identify genes enriched in the germinal neuroepithelium, so as to distinguish those expressed in neural
progenitors from those expressed in more differentiated cells in vivo. NS cultures were characterized by the coordinate upregulation of genes
involved in cell cycle progression, DNA synthesis, and metabolism, not simply related to general features of cell proliferation, since many
of the genes identified were highly enriched in the CNS ventricular zones and not widely expressed in other proliferating tissues.
Components of specific metabolic and signal transduction pathways, and several transcription factors, including Sox3, FoxM1, and PTTG1,
were also enriched in neural progenitor cultures. We propose a putative network of gene expression linking cell cycle control to cell fate
pathways, providing a framework for further investigations of neural stem cell proliferation and differentiation.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Neural stem cells (NSC) give rise to progenitor cells,
which expand by rapid proliferation before undergoing cell
cycle arrest followed by differentiation along one of three
central nervous system (CNS) cell lineages, neurons, astro-
cytes, and oligodendrocytes (Reynolds and Weiss, 1996;
Levison and Goldman, 1997). The molecular mechanisms
by which multipotent CNS stem cells are induced to differ-
entiate into lineage-specific progenitors and further into
various CNS cell types are just beginning to be elucidated
(Reynolds and Weiss, 1992; Levison and Goldman, 1997;
Lillien, 1998; Tropepe et al., 1999; Caviness et al., 2000;
Lee et al., 2000; Anderson, 2001; Geschwind et al., 2001;
Rowitch et al., 2002; Wichterle et al., 2002). A number of
factors have been implicated (e.g., Ferri and Levitt, 1995;
Davy et al., 1999; Osterhout et al., 1999; Learish et al.,
2000; Takeuchi et al., 2000), including several signaling
pathways and transcription factors, such as Sox1 and Sox2
(Sasai et al., 2001), the homeobox genes (Overton et al.,
2002), and several members of the bHLH family of tran-
scription factors, such as Olig2 and Neurogenin (Zhou et al.,
2000; Zhou and Anderson, 2002; Sun et al., 2001). Simi-
larly, genes such as Notch have been demonstrated to play
a role in neural stem cell proliferation or maintenance and
may be involved in lineage determination as well (Morrison
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et al., 2000; Gaiano and Fishell, 2002). Identification of
other factors that are involved in stem cell proliferation and
differentiation programs has become one of the immediate
goals of our work (e.g., Geschwind et al., 2001; Terskikh et
al., 2001; Kornblum and Geschwind, 2001), since such
knowledge will advance the understanding of CNS devel-
opment and the potential for the use of stem cells as ther-
apeutic agents for brain injury of neurodegenerative dis-
eases.
Much of the available knowledge regarding neural stem
cells comes from studies carried out in vitro. To resolve the
complexities of neuro- and gliogenesis, a simplified in vitro
system based on culturing of unmodified neural progenitors
in the presence of growth factor (bFGF), called neuro-
spheres, was developed (Reynolds and Weiss, 1996; Qian et
al., 2000). Previous studies have shown that cells within
neurospheres (NS) have certain characteristics of stem cells:
(1) they are self renewing in the presence of appropriate
mitogens, (2) they can be clonally expanded, and (3) they
are capable of producing the major cell types of brain tissue:
neurons, astrocytes, and oligodendrocytes (Reynolds and
Weiss, 1992, 1996; Tropepe et al., 1999; Mayer-Proschel et
al., 1997). By exchanging the media that is more conducive
for differentiation, early progenitor cells present in NS cul-
tures spontaneously undergo differentiation along the cell
lineage as a function of time in culture, modeling the phe-
notypic changes normal neural progenitor cells undergo as
they migrate away from the ventricular zone (O’Rourke et
al., 1997). These cells can be grown for long periods of time
while retaining the potential to differentiate into nervous
tissue (Reynolds et al., 1992; Reynolds and Weiss, 1992,
1996; Gritti et al., 1996; Tropepe et al., 1999). The NS
system is suitable for genetic manipulation, yields large
numbers of cells, and allows precise manipulation of the
culture environment. Therefore, the examination of such a
simplified in vitro system significantly reduces the complex-
ities of neuro- and gliogenesis and furthermore allows an
increase in our knowledge of the regulatory factors control-
ling the division and differentiation of NSC during normal
brain development on a biochemical level.
Recently, we demonstrated that a NS culture system
combined with representational difference analysis (RDA)
subtraction was useful for identification of a subset of NSC
and progenitor cell genes (Geschwind et al., 2001). In situ
hybridization study confirmed the germinal expression pat-
terns for many of these genes, supporting their potential
relevance to in vivo stem cell biology. In the present study,
we have used an in house printed cDNA microarray based
on the mouse Gem1 sequence verified clone set (In-
cyteGenomics; Palo Alto), to further and more broadly
explore the genes and pathways important for neural pro-
genitor biology. Specific alterations in a putative network
linking cell cycle to cell fate decisions and metabolic
pathways were identified. The complete database can be
accessed at our laboratory Web site (http://geschwindlab.
medsch.ucla.edu/index.html).
Materials and methods
Cell culture and immunocytochemistry
Neural progenitor cells were obtained from prenatal day
1 mouse pups (P0) from a CDN-1 mother (Harlan-Sprague
Dawley) and cultured as described in Geschwind et al.
(2001). After 2 weeks, half of the cells were differentiated
for 24 h (Geschwind et al., 2001). To acquire the percentage
of cells present in the differing growth conditions, both
neurospheres (NS) and colonies differentiated for 24 h (DC)
were dissociated with 0.05% trypsin (Gibco). Then, the
liberated cells were replated on poly-L-lysine- coated cov-
erslips. Immunocytochemistry was performed with antibod-
ies directed against -tubulin (Tuj1) to identify neurons
(Ciccolini and Svendsen, 1998), glial fibrillary acidic pro-
tein (GFAP) to identify astrocytes (Morrison and De Vellis,
1981), and Nestin to identify uncommitted progenitors
(Williams et al., 1997; Murray and Dubois-Dalcq, 1997;
Ben-Hur et al., 1998; Mayer-Proschel et al., 1997). Cells
positive for each of the antibodies were counted under a
fluorescence microscope.
RNA extraction
Total RNA from undifferentiated and differentiated neu-
rospheres was extracted by using acid phenol extraction
(Trizol LS; GIBCO/BRL) as recommended by the manu-
facturer. The RNA was dissolved in TE buffer and stored at
80°C. The purity of RNA was checked by measuring the
optical density at 260 and 280 nm. The quality was con-
firmed by gel electrophoresis.
Microarrays and data analysis
Probe synthesis and hybridizations were performed ac-
cording to the tyramide signal amplification (TSA) protocol
(NEN; PerkinElmer) with minor modifications (Karsten et
al., 2002). Total RNA (1.5 g) was used to synthesize and
label cDNA for each hybridization, in which NS and DC
samples were cohybridized onto the array in a two-dye
competitive hybridization. In total, four independent repli-
cates (from independent litters and cultures) were per-
formed in duplicate (with dye flipping) on mouse 9K arrays
printed at the UCLA Microarray Core facility (http://www.
genetics.ucla.edu/microarray/), in order to find the most
consistent changes in gene expression. Microarrays were
scanned by using the Array Scanner 418 (GMS/Af-
fymetrix). The images were analyzed with ImaGene 4.2
using auto segmentation method set for background and
buffer width of 3 pixels (Biodiscovery, Marina Del Ray).
Two distinct analytic methods were used to identify
differentially expressed genes with high confidence. In the
first analysis, quantified signal intensity data were down-
loaded onto GeneSpring 3.1.1, (Silicon Genetics, Redwood
City). Poor quality spots flagged in Imagene were omitted
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and the local background was subtracted from remaining
signal intensities. Only genes whose signal intensities were
twofold greater than the local background were considered
present. The ratio of signal intensities for each gene was
taken and global normalization of channels was performed
dividing each ratio by the mean of all ratios. Differentially
regulated genes in two conditions were identified as those
with ratios above 2.0 in at least three out of four indepen-
dent replicate experiments. These criteria were based on the
95% confidence interval determined from self-hybridization
experiments and comparisons of independently cultured NS
cell lines using the TSA labeling technique (Karsten and
Geschwind, 2002).
In parallel with GeneSpring analysis, the data set was
analyzed by using nonlinear normalization, and determina-
tion of a threshold of differential expression based on the
nonparametric false discovery rate method as described in
Sabatti et al. (2002). The replicates with highest correlation
were selected (Sabatti et al., 2002), leaving three out of the
four replicate experiments in this analysis. The signal in-
tensities were corrected by subtraction of smoothed back-
ground derived using four-nearest-neighbor averages. The
signals were log transformed and extreme outliers were
eliminated. The signals were further normalized by using
nonlinear rank- based normalization, and ratios of the log
values were obtained (Sabatti et al., 2002). Differentially
regulated genes were identified by applying a universal
threshold based on normality and corresponding to an av-
erage fold-change of 2.4, which corresponded to a false
discovery rate of 0.05. In order to identify the most robust
changes in gene expression, the data sets derived from both
analyses were overlaid, and genes identified as differentially
expressed in both analyses were selected.
In situ hybridizations
Prior to the in situ hybridization, all selected clones were
sequenced (ABI Prizm 3700, Applied Biosystems). In situ
hybridization was performed as described by Geschwind et
al. (2001) with minor modifications. Slides contained two
sagittal sections through entire E14 embryos, coronal sec-
tions through E17 fetus heads, and coronal sections through
P0 brains. The digitized film images were processed with
Adobe Photoshop 6.0 and Adobe Illustrator 9.0.1 for opti-
mal visualization of the hybridization signals.
Results
Cell composition of NS and differentiated cells
Our previous study functionally documented that NS
cultures contain 10-fold more neural stem cells than the DC
condition (Geschwind et al., 2001). However, neurospheres
are heterogeneous cell cultures containing, along with neu-
ral stem cells, many classes of progenitors and already
differentiated cells. In the current study, we used immuno-
cytochemistry to evaluate the cell types present in the NS
and DC conditions. As expected, Nestin labeling was in-
creased in NS, and differentiated cells yielded a signifi-
cantly higher percentage of neurons and astrocytes than
undifferentiated neurospheres (Fig. 1). The data indicate
that, after 24 h of bFGF removal, there was a substantial
decrease (34%) in the proportion of neural progenitors and
increase in the proportion of cells expressing mature cell
type markers: neurons (56%), astrocytes (95%), and oligo-
dendrocytes (not shown; Geschwind et al., 2001). This
suggests that, while some degree of fate commitment occurs
within the neurosphere environment, 24 h growth factor
removal greatly accelerates this process in part by decreas-
ing the number of neural stem cells, as previously demon-
strated (Gritti et al., 1996; Geschwind et al., 2001).
Determination of gene expression patterns associated with
NSCs
A cDNA array containing 8734 mouse genes (9K array;
http://www.genetics.ucla.edu/microarray/) based on the
Fig. 1. Cellular composition of undifferentiated NS and NS differentiated
for 24 h (DC). Nestin, Tuj1, and GFAP, which are commonly used markers
for uncommitted progenitors, neurons, and astrocytes, respectively, were
used for labeling the cells in NS and DC. After placing NS in differenti-
ating conditions for 24 h via growth factor withdrawal, GFAP and Tuj1
labeling were used to determine the percentages of mature cellular ele-
ments. (A) Labeling of NS and NS differentiated for 24 h with Nestin,
Tuj1, and GFAP. (B) Proportion of uncommitted progenitors (Nestin),
neurons (Tuj1), and astrocytes (GFAP) in NS and NS cultures differenti-
ated for 24 h. Results are arithmetical means SD for five different counts
in each case. There is a 34% reduction in nestin () immunoreactivity, a
56% increase in Tuj1 () (a 1.5 increase), and a 95% increase in GFAP
() immunoreactivity (a 2 increase) over a course of 24 h differentiation.
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Unigene GEM1 set, containing 2700 known genes and an
additional 6000 uncharacterized genes or ESTs, was used to
characterize the expression pattern underlying the prolifer-
ation and early differentiation program of mouse neural
progenitors. This array has the advantage that it contains
sequence verified clones that perform well in microarray
hybridization experiments and consists of genes of varying
abundances, including many in the low-abundance category
based on either previous microarray expression studies or
EST sequencing data.
Analysis of signal intensity revealed that 83 and 79% of
sequences on the array were identified as present, as they
generated average signal intensity more than 2-fold above
local background when hybridized with the NS and DC
cDNA, respectively. Using the first analysis method (mate-
rials and methods), with global normalization and a 2-fold
difference threshold in at least 3 out of 4 independent
experiments, 197 genes were identified as enriched in NS
cultures, whereas 113 genes were downregulated. In paral-
lel, the same data set was analyzed by using nonlinear
normalization and a false discovery threshold (see materials
and methods; Sabatti et al., 2002), identifying 188 genes
enriched in NS and 115 genes downregulated. To further
limit the false positive rate, we combined both data sets,
which in total resulted in 204 differentially expressed genes
and ESTs (126 enriched in NS and 78 downregulated in
NS), representing a 67% overlap between the two analytic
approaches (Table 1).
We were able to compare these changes with previous
gene expression data, providing independent confirmation
of some of these differentially expressed genes. Of the 88
NS-specific genes previously identified by our group using
microarrays consisting of RDA clones (average insert
length 300–600 bp), 31 were present on the 9K array.
Twenty-three of these genes (77%) met the previous criteria
used for the determination of differential regulation
(Geschwind et al., 2001). This criterion of 1.5-fold or more
differential expression, although less stringent than the cur-
rent criteria, was independently verified by Northern blot-
ting and in situ hybridization for a large fraction of the
previously identified genes (Geschwind et al., 2001). Only 8
of the previously identified genes (26%) satisfied the more
stringent criteria for differential regulation used in this
study. Since the majority of the 88 previously identified
genes have been independently verified as differentially
expressed under these conditions, this indicates that the
current criteria of differential expression, while very spe-
cific, are not as sensitive as more relaxed criteria. However,
we applied such strict standards to be relatively certain that
the genes identified were correct, so as not to weaken our
downstream analysis of pathways. The list of differentially
expressed genes using each of the two different methods
and raw ratio data is posted on our Web site to allow the use
of other criteria to identify candidate genes of interest
(http://geschwindlab.medsch.ucla.edu).
Confirmation of microarray data
Given the highly organized and heterogeneous structure
of the central nervous system, where and when a gene is
expressed in the brain can have significant functional im-
plications. We therefore expected that most of those genes
having a true role in progenitor biology, while not neces-
sarily showing germinal zone restriction, should show rel-
atively high expression in the ventricular zone (VZ) or the
subventricular zone (SVZ) of the developing brain (e.g.,
Geschwind et al., 2001; Terskikh et al., 2001; Luo et al.,
2002). In some cases, we were able to take advantage of
previously published work to confirm that several genes
identified as NS-enriched were enriched in CNS germinal
regions (ventricular and subventricular zones). Out of 71
known genes enriched in NS cultures identified in this
study, 20 were previously studied and 17 (85%) of these
showed enriched germinal zone expression in the develop-
ing CNS at embryonic stages (Table 2).
We performed 23 additional in situ hybridizations for NS
genes not previously studied at these embryonic stages. We
chose genes from among those with the lowest to the high-
est fold upregulation, so as to obtain a crosssectional view
of in vivo expression patterns. This revealed enriched ger-
minal expression in 18 genes in at least 1 of the ages
analyzed (Figs. 2 and 3 ). Combined with literature data, 30
(83%) out of 36 NS-enriched genes studied were expressed
in the germinal zone during embryonic development, al-
though only 11 were relatively VZ exclusive (Table 2; Figs.
2 and 3). For example, Sox3, TenascinC, and Cbfb have a
highly specific expression in the germinal zone throughout
early CNS development (E14, E17, P0), and their expres-
sion patterns are in agreement with previously published
data. AA476079 is a part of Ssrp1: structure-specific rec-
ognition protein 1, a transcriptional regulator, which was
originally isolated as a factor interacting with c-Myc onco-
protein (Bunker and Kingston, 1995). It has a highly spe-
cific expression in the germinal zone throughout CNS de-
velopment (Fig. 2). Apelin has a highly specific expression
pattern in the germinal zone throughout development, but
the expression level seems to decline by P0. Although
Nicastrin and TK1 are not CNS-specific, within the devel-
oping nervous system their expression is highly restricted to
the germinal zone (Fig. 2). W11380 represents a part of a
novel gene XM_134100 similar to cytoskeleton associated
protein 2, and although not CNS-specific, has a highly
enriched expression pattern in the germinal zone (Fig. 2).
Lrrfip1 is enriched in the germinal zone, but its expression
level declines during CNS development (Fig. 2).
Some of the genes not previously associated with neural
progenitor proliferation or differentiation were identified as
having enriched germinal zone expression in this study. A
number of these genes revealed strong germinal zone ex-
pression at E14 and E17 (Table 2; Fig. 3). Kpnb3; Srb1,
Hig1, and PTDSR are enriched in the germinal zone, but
widely expressed in the CNS during development with
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Table 1
Genes enriched in NS or DC cultures.
Accession No. Gene Cell
cycle
Cell
org.
Metabolism NA
met
Protein
met
Transport Stress Death Cell–cell Signal
transd.
Ext
stim
Development
Genes upregulated in undifferentiated neurospheres
AA008579 Abcg2 ATP-binding cassette, sub-family G
(WHITE), member 2
X X
AA537637 Acas1 Acetyl-Coenzyme A synthetase 1 X
W33415 Acly ATP citrate lyase X
AA403828, AA387076 Akap12 A kinase (PRKA) anchor protein
(gravin) 12
X
W64238 Apel-pending Apelin X
AA087036 Arl6ip2 ADP-ribosylation-like factor 6
interacting protein
X X
AA003372 Bcat1 Branched chain aminotransferase 1,
cytosolic
X
AA030640 Bnip3 BCL2/adenovirus E1B 19 kDa-
interacting protein 1, NIP3
X
AA238417 Cals1 Carbonic anhydrase-like sequence 1 X
AA396324 Ccnb1 Cyclin B1 X
AA111722 Ccnd1 Cyclin D1 X
W98440 Ccnd2 Cyclin D2 X
AA035888 Cdc2a Cell division cycle 2 homolog A (S.
pombe)
X X
AA153012 Chaf1a Chromatin assembly factor 1, subunit A
(p150)
X X X X
AA547555 Cks1 CDC28 protein kinase 1 X
AA466508 Clic4 Chloride intracellular channel 4
(mitochondrial)
X
AA068939 Cnbp Cellular nucleic acid binding protein X
W14146 Cs Citrate synthase X
AA177976 Cugbp2 CUG triplet repeat, RNA-binding
protein 2
X X
AA267000 Ect2 Epithelial cell transforming sequence 2
oncogene
X X
AA204262 Eno1 Enolase 1, alpha non-neuron X
AA002514 Fabp7 Fatty acid binding protein 7, brain X X X X
AA066741, AA032807 FoxM1 Forkhead box M1 X X X
AA237872 Gcs1 Glucosidase I X
AA255078 Glk Galactokinase X
AA276216 Gpi1 Glucose phosphate isomerase 1 complex X
AA220714 Gys3 Glycogen synthase 3 X
AA414831 Hig1-pending Hypoxia induced gene 1 X
AA275111 Hmgb2 High mobility group protein 2 X X
AA049862 Hrb HIV-1 Rev binding protein (nuclear) X
AI892096 Idh3a Isocitrate dehydrogenase 3 (NAD)
alpha
X
AA003218 Kife1 Kinesin family member C1 X
W66752 Kpnb3 Karyopherin (importin) beta 3 (nuclear) X
AA265396 Lag Leukemia-associated gene (stathmin 1) X X
AA239254 Lce-pending Long chain fatty acyl elongase
(mitochondrial)
X
(continued on next page)
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Table 1 (continued)
Accession No. Gene Cell
cycle
Cell
org.
Metabolism NA
met
Protein
met
Transport Stress Death Cell–cell Signal
transd.
Ext
stim
Development
W30242 Lrrfip1 Leucinerichrepeat(inFLII)interacting
protein 1
X
AA011839 Mcmd2 Mini chromosome maintenance deficient
2 (S. cerevisiae)
X X X
AA259788 Mcmd4 Mini chromosome maintenance deficient
4 (S. cerevisiae)
X
AA016759 Mcmd6 Mini chromosome maintenance deficient
6 (S. cerevisiae)
X X
AA544948 Mcmd7 Mini chromosome maintenance deficient
7 (S. cerevisiae)
X X
AA242457 Mmp15 Matrix metalloproteinase 15 X
W84014 Mthfd2 Methylenetetrahydrofolate
dehydrogenase (NAD  dependent)
X
AA009268 Myc Myelocytomatosis oncogene X X
W13528 Myh8 Myosin, heavy polypeptide 8, skeletal
muscle, perinatal
X X
AA118848 Nicastrin Nicastrin X
W63828 Nup88 Nucleoporin 88 kDa X
W88183 Olig2 Oligodendrocyte transcription factor 2 X X
AA116947 Pcna Proliferating cell nuclear antigen X X
AA423301 Pdha1 Pyruvate dehydrogenase E1 alpha
subunit
X
AA203878 Pfkfb1 Inducible 6-phosphofructo-2-kinase X
AA475930 Pgcp-pending Plasma glutamate carboxypeptidase X
W98869 Ptbp1 Polypyrimidine tract binding protein X
AA007773 Ptdsr Phosphatidylserine receptor X X
AA250500 Pttg1 Pituitary tumor-transforming 1 X X
W41878 Pycs Pyrroline-5-carboxylate synthetase X
A1327394 Racgap1 Rac GTPase-activating protein 1, Ras
superfamily
X
W83609 Rbp1 Retinol binding protein 1, cellular X X
AA108363 Rpl3 Ribosomal protein L3 X
W47785 Rps6kal Ribosomal protein S6 kinase
polypeptide 1
X X X
AA267034 Ruvbl2 RuvB-like protein 2 X X
W82738 Scarb1 Scavenger receptor class B1 X X X
W91516 Sell Selectin L X X X
AA033138 Slc25a5 Solute carrier family 25 (mitochondrial) X
AA000101 Sox3 SRY-box containing gene 3 X X
AA190123 Tacc3 Transforming, acidic coiled-coil
containing protein 3
X X X
AA041834 Tk1 Thymidine kinase 1 X
AA270625 Tnc Tenascin C X
AA212159 Tubb5 Tubulin, beta 5 X
AA020155 Upp Uridine phosphorylase X
AA020307 Vldlr Very low density lipoprotein receptor X X X X
AA178164 Zfp26 Zinc finger protein 26 X
Genes upregulated during 24 h differentiation
AA203809 Abca1 ATP-binding cassette, sub-family A
(ABC1), member 1
X X
AA242060 Anxa7 Annexin A7 X
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Accession No. Gene Cell
cycle
Cell
org.
Metabolism NA
met
Protein
met
Transport Stress Death Cell–cell Signal
transd.
Ext
stim
Development
W98956 Aplp1 Amyloidbeta(A4)precursor-like
protein 1
X
W64242 Arhn Aplysia ras-related homolog N (RhoN) X
AA542206 Arl6ip2 ADP-ribosylation-like factor 6
interacting protein 2
X X
AA050218 Cd151 CD151 antigen X
AI385551 Cirbp Cold inducible RNA-binding protein X X X
W63987 Cnp1 Cyclic nucleotide phosphodiesterase 1 X
AA277495 Cpt1a Carnitine palmitoyltransferase 1, liver X X
AA271275 Cpxm1 Carboxypeptidase X 1 (M14 family) X
AA231358 Crya2 Crystallin, alpha 2 X
AA174215 Cts1 Cathepsin L X
AA472492 Cxcl9 Chemokine (C-X-C motif) ligand 9 X X X X
W64388 Gadd45b Growth arrest and DNA-damage-
inducible 45 beta
X X X X X
AA000036 Gcn512 General control of amino acid
synthesis-like 1
X X X
AA288467 Glycam1 Glycosylation dependent cell adhesion
molecule 1
X
AA178779 Icsbp Interferon concensus sequence binding
protein
X X
AA036176 Lamb2 Laminin, beta 2 X
AA087193 Lcn2 Lipocalin 2 X
AA498356 Map11c3 Microtubule-associated protein 1 light
chain 3
X
AA028410 Mapt Microtubule-associated protein tau X X
AA222497 Mdk Midkine X X X X
AI450527 Mocs2 Molybdenum cofactor synthesis 2 X
AA451395 Nfatc2 Nuclear factor of activated T-cells,
cytoplasmic 2
X
AA265273 Psen2 Presenilin 2 X X X X
AA108857 Ptgds Prostaglandin D2 synthase (21 kDa,
brain)
X X
AA466432 S100a1 S100 calcium binding protein A1 X X X X
AA267952 S100a6 S100 calcium binding protein A6
(calcyclin)
X X
W75931 Scg3 Secretogranin III X
AA276440 Sepp1 Selenoprotein P, plasma, 1 X X X
W47914 Siat8b Sialyltransferase 8 (alpha-2, 8-
sialytransferase) B
X X
AA008222 Smoh Smoothened homolog (Drosophila) X X
W34029 Snta1 Syntrophin, acidic 1 X X
W67105 Tagln3 Transgelin 3 X
AA145784 Timp3 Tissue inhibitor of metalloproteinase 3 X
AA003303 Tjp2 Tight junction protein 2 X
W11746 Tuba4 Tubulin alpha 4 X
AA473123 Ugp2 UDP-glucose pyrophosphorylase 2 X
AA272198 Uros Uroporphyrinogen III synthase X
Note. LocusLink gene symbols are listed (http://www.ncbi.nlm.nih.gov/LocusLink) alongside the Accession nos. representing the sequences used to construct the microarray. When applicable, identified
genes were assigned to 1 or more of 12 predefined functional groups based on information provided by The Gene Ontology Consortium (http://www.geneontology.org/). The following functional groups were
used: Cell cycle, cell cycle/proliferation; Cell org, cell organization and biogenesis; Metab, metabolism with exception of protein and nucleic acid metabolism; NA metab, nucleic acids metabolism/
transcription; Prot metab, protein metabolism; Transport, transport; Stress, stress response; Death, cell death; Cell–cell, cell adhesion/cell–cell signaling; Signal, signal transduction; Ext stim, response to
external stimulus; Devel, development.
171
S.L.K
arsten
et
al./D
evelopm
entalBiology
261(2003)165
–182
Table 2
Germinal zone expression of identified genes based on in situ hybridization data at four different ages
Gene E12.5 E14 E17 P0 Reference
Genes upregulated in NS
Sox3 — H H H Collignon et al., 1996; Fig. 2
Tk1 — H H H Fig. 2
EST, W11380 — H H H Fig. 2
Nicastrin — H H H Fig. 2
FoxM1 — H H H Fig. 2
Lrrfip1 — H H H Fig. 2
Olig2 — H — — Takebayashi et al., 2000
Racgap1 — H — — Arar et al., 1999
Apelin — H M N Fig. 2
Tenascin C — H H M Dorries et al., 1994; Stoykova et al., 1997; Fig. 2
Fabp7 — H M M Feng et al., 1994; Fig. 3A
Kpnb3 — M M M Fig. 3A
EST, AA476079 — M M M Fig. 3A
Ccnd2 M M M H Geschwind et al., 2001
Cnbp M M M U Kingsley et al., 1996; Fig. 3A
Tacc3 M M M — Sadek et al., 2000
Cugbp2 M M M — Choi et al., 1999
Hig1 — M M U Fig. 3A
PCNA — M M — Ino et al., 2000
Gys3 — M N M This report
Hmg2 M — M — Ronfani et al., 2001
Cbfb U M M N Wang et al., 1996; Fig. 3A
Ccnd1 — M M M Sicinski et al., 1995; Geschwind et al., 2001
Cdc2a — M — — Besset et al., 1998
Pttg1 M M — — Tarabykin et al., 2000
Ptdsr — M U N Fig. 3A
Ptbp M — — — Lillevali et al., 2001
Rbp1 M — — — Dolle et al., 1990
Selectin — U M U Fig. 3A
Srb1 — U M U Fig. 3A
Pde4B — U U U Fig. 3A
Stathmin 1 — U U U Sugiura et al., 1995; Fig. 3A
C-myc N N N — Schmid et al., 1989
Akap12 — N N N Fig. 3A
Vldlr — N N N Trommsdorff et al., 1999; Fig. 3A
Pgcp — N N N Fig. 3A
VZ/SVZ 8/10 25/33 22/29 13/24 Total: 30/36
Genes upregulated in DC
Smoh — H H M Fig. 3B
Siat8b M M — — Ong et al., 1998
Gcn511 — U M M Fig. 3B
Aplp1 — M — — Lorent et al., 1995
Midkine M — — — Kadomatsu et al., 1990
Nfatc2 — U U U Fig. 3B
EST, W58977 — U U U Fig. 3B
Psen2 — N N N Fig. 3B
Ptgds N N N — Kume et al., 1998; Hoffmann et al., 1996
Cpxm1 — N N — Lei et al., 1999
Crya2 N — — — Benjamin et al., 1997
Cnp1 N — — — Peyron et al., 1997
Timp3 — N — — Apte et al., 1994
Sepp1 — — N — Steinert et al., 1998
Snta1 — — — N Gorecki et al., 1997
VZ/SVZ 2/5 3/10 2/8 2/6 Total: 5/15
Note. H, highly specific germinal expression; M, enriched in germinal zone; U, ubiquitous expression in the CNS; N, no significant germinal expression.
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laminar-specific expression patterns in the cortex at P0
(Table 2). FABP7, previously associated with neuronal mi-
gration, is enriched in the germinal zone, but is also ex-
pressed in other CNS regions (Fig. 3). Three genes showed
choroid plexus expression at least at one stage. Gys3 has an
enriched germinal expression pattern at E14, but has low
expression at E17, with higher expression levels in the
choroid plexus. At P0, its expression is enriched in the
germinal zone (data not shown). Plasma glutamate car-
boxypeptidase (Pgcp) showed enriched expression in the
meninges and the choroid plexus (Fig. 3). Stathmin is ubiq-
uitously expressed with enriched expression in the CNS
germinal zones at E14 and choroid plexus at all ages ana-
lyzed (Fig. 3).
Several genes previously associated with neurogenesis or
migration, but not associated with neural progenitor func-
tion, do not show a VZ-or SVZ-specific pattern. VLDLR is
expressed highly in the intermediate zone/cortical plate at
E14, with some expression in the germinal zone, and is
known to function in neuronal migration. CNBP is ubiqui-
tously expressed with enriched regions in the germinal zone
and the outer cortical laminae at E17, when the expression
is also prominent in the choroid plexus, and globus pallidus.
Using the same criteria to stratify expression patterns for
NS enriched genes, only 3 out of 10 previously studied NS
downregulated genes revealed enriched germinal expres-
sion. We performed additional in situ hybridization study of
5 DC genes and showed that 3 of them, NF- ATc2, Smoh,
and Gcn511, are also enriched in VZ. In total, only 6 (40%)
out of 15 NS downregulated genes studied were expressed
in the germinal zone during the embryonic stages, signifi-
Fig. 3. In situ expression patterns of NS (A)- and DC (B)-enriched genes
on the three different ages of mouse brain. For details, see Fig. 2 legend.
Fig. 2. In situ expression patterns of NS enriched genes on the three
different ages of mouse brain. The arrows indicate the germinal zone at
each age. (A) Images of film autoradiographs of the NS enriched genes
with high germinal zone expression are shown. The images were taken
from sagittal sections of whole embryo at E14, coronal sections of E17
head, and coronal sections of P0 brain hybridized to 35S- labeled antisense
cRNAs. (B) High VZ TK1 expression in E17 VZ. Dark field montage
shows silver grains (TK1 mRNA) in hematoxylin and eosin-stained section
of E17. Higher magnification demonstrates TK1 expression (silver grains)
over superficial VZ, which are absent from the periventricular deep VZ,
consistent with the known mitotic cycling pattern of neural precursors.
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cantly different from those enriched in NS, providing in
vivo confirmation of the relevance of the in vitro gene
expression differences (P  0.005, Chi square).
Gene categorization and functional group analysis
To understand the biological significance of the overall
changes in gene expression, identified genes were catego-
rized based on their involvement in specific biological pro-
cesses by using the Gene Ontology database (http:://www.
geneontology.org/#godatabase; The Gene Ontology Con-
sortium, 2001). The majority of these changes (62%) were
increases in gene expression in NS cultures, a finding con-
sistent with a more pluripotential, proliferative state, reflect-
ing decreased cellular specialization relative to the differ-
entiated state. Identified genes with official names were
sorted in alphabetical order and categorized into 1 or more
of 12 functional categories based on the Gene Ontology
database (Table 1; Fig. 4).
Genes significantly regulated in NS were not evenly
distributed across functional categories, highlighting the
roles of several specific biological processes (Fig. 4). For
example, we observed only a minimal enrichment of apop-
tosis-related genes (7 genes out of 99 present on the array),
consistent with the observations of Luo et al. (2002) using
a much smaller focused array. In contrast, several distinct
functional groups showed significant enrichment in NS cul-
tures based on their overall representation on the array:
cell-cycle and proliferation (P  0.014), metabolism (P 
0.006), signal transduction (P  0.022), and response to
external stimulus (P  0.031; Fig. 4). Genes of cell–cell
signaling and cell adhesion varied most significantly be-
tween NS and DC (P  0.012; Fig. 4). Apart from genes
whose overexpression was most likely a result of rapid
proliferation of cells in NS cultures, a number of genes were
isolated that play major roles in protein and nucleic acid
metabolism or transcription regulation, in addition to novel,
previously uncharacterized genes, that we are not able to
categorize. Novel genes and ESTs comprised 53 clones
enriched in NS and 39 downregulated in NS, and although
uncharacterized genes are the most abundant category, this
is not out of proportion to their abundance on the array.
Defining functional relationships among identified genes
To dissect the molecular mechanisms and pathways in-
volved in the regulation of neural progenitor biogenesis, we
performed an extensive literature search on the differen-
tially regulated genes and their downstream targets. Infor-
mation obtained was used to construct putative relationships
amongst genes and their products based on genetic and
biochemical data. Fig. 5 depicts previously established re-
lationships between genes identified in the course of this
study. The most striking observation is that many genes
identified as enriched in NS are either involved in various
aspects of cell-cycle control or represent the downstream
targets of cell-cycle regulation (Fig. 5). In addition, meta-
bolic pathways, including nucleic acid metabolism, transla-
tion, and protein processing, are NS-enriched.
Cell-cycle and proliferation machinery
The majority of cell cycle genes that were differentially
expressed (70%) were upregulated in neural progenitors,
consistent with their self-renewal properties (Fig. 4). Spe-
cific genes included the cyclins B1, D1, and D2, the cell
division cycle 2 homolog, cdc28 protein kinase, and others
Fig. 4. Abundance of differentially expressed genes grouped according to
their functional category. (A) Graphical representation of relative abun-
dance of differentially expressed genes in NS and DC grouped according
to their involvement into biological processes. *, The group of genes that
were most significantly regulated in NS and DC conditions relative to each
other. (B) Number of genes enriched in each functional category and their
corresponding P values in NS and DC conditions. The significance of the
enrichment for genes from specific functional groups during 24 h differ-
entiation (P values) were determined by comparison of the percentage of
genes altered in expression in a particular functional group to the overall
percentage of change in genes during differentiation. M9K, number of
genes in the functional categories on the array. NS and DC are the numbers
of genes enriched in the particular category in undifferentiated and differ-
entiated neurospheres, respectively. NS-vs-M9K and DC-vs-M9K provide
P values to identify functional categories significantly overrepresented in
either NS or DC relative to abundance of genes within each category on the
array. The NS-vs-DC column provides significance levels for the genes
enriched in NS in a given category with respect to the genes enriched in
DC.
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(Table 1). These genes play a central role in controlling
gene expression at the G1-S phase transition of the cell
cycle by orchestrating the expression of genes whose prod-
ucts are required for nucleotide biosynthesis, DNA replica-
tion, and cell cycle progression, which also show concom-
itant changes in their expression. The INK4 family of
cyclin-dependent kinase inhibitors, which control G1 pro-
gression, induces cell-cycle arrest. The only members of
this family present on the array are Cdkn2c (p18) and
Cdkn1a (p21), and both of them are not enriched in the NS.
Fig. 5 summarizes the putative network of cell cycle-related
transcriptional regulation occurring in NS cultures. The
Fig. 5. Hypothetical network of regulatory factors potentially involved in the regulation of neural progenitor cell cycle and differentiation identified into the course
of this study. Previously established relationships between identified genes and their relation to the cell cycle regulation are shown. Green font represents the genes
enriched in NS, while red font labels the genes downregulated. Overlapping figures indicate that the gene products are known to interact on the protein level. As
the cDNA microarray used does not represent all the genes in the genome, some functional relations are not as evident. In such cases, the absent member representing
the link between the genes or gene products is indicated with an empty circle (e.g., pRb complex of Cdk4). The eukaryotic cell cycle is governed by cyclin-dependent
protein kinases (CDKs) whose activities are regulated by cyclins and CDK inhibitors. Here, we hypothesized that the retinoblastoma protein complex (pRb) pathway
(Yoshikawa, 2000) plays a central role in neural stem cell proliferation. G1/S phase transition is promoted by Cyclin D1, D2, and Cdk4 protein complex, which
inhibits pRb protein complex in turn releasing a cascade of regulatory events resulting in activation of DNA replication, cyclin B1 complex, and cytokinesis genes.
Ect2 and c- Myc enriched in NS positively regulate cyclins D1 and D2 (Leone et al, 2001; Westwick et al, 1998). Expression of c-Myc in neural progenitors might
be regulated by exogenous bFGF and two transcriptional activators: CNBP and PTTG (Michelotti et al, 1995; Pei 2001). Activated cyclin B1/cdk1/cks1 protein
complex is required for the G2-to-M transition in cell division (see Discussion; Elledge, 1996; O’Connor, 1997). Cdk1 (cdc2) and cyclin B1 are also positively
regulated by c-Myc, PTTG1, and FoxM1, facilitating transition from G2 to M phase. Gadd45b, a protein implicated in apoptosis and terminal differentiation, interacts
with Cyclin B1/cdc2 complex, inhibiting its activity and subsequently initiates neuronal differentiation (Nahreini et al. 2001; Vairapandi et al., 2002). Another factor
promoting cell cycle exit at G1/S check point is NFATC2, which negatively regulates the expression of Cdk4 associated with Cyclin D1 and D2 (Baksh et al., 2002).
This promotes reentry of differentiating nonproliferative state. Several genes previously implicated in neurogenesis or neural stem cell fate determination are listed
under Differentiation.
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implications of these regulatory relationships are addressed
in detail in Discussion. But, it is becoming clear that cell
cycle and DNA synthesis control is a fundamental property
of neural stem cells that is not simply related to their
increased rate of proliferation relative to differentiated cells,
but has fundamental implications for cerebral cortical cell
fate, patterning, and ultimately the evolution of the cerebral
cortex (Kornack and Rakic, 1998; Caviness et al., 1999,
2000; Takahashi et al., 1999; Haydar et al., 2000; Rakic,
2000; Coskun and Luskin, 2001; Geschwind et al., 2001;
Chenn and Walsh, 2002; Luskin and Coskun, 2002).
Nucleic acid metabolism
Consistent with the increase in expression of G1-S cell
cycle regulatory genes, there was a concomitant increase in
the expression of genes involved in nucleic acid biosynthe-
sis, DNA replication, repair, and chromatin maintenance in
NS (Fig. 4). Genes with a role in nucleic acid biosynthesis,
DNA replication, and chromatin maintenance included thy-
midine kinase 1 (TK1), Mcmd2, Mcmd4, Mcmd6, Mcmd7,
chromatin assembly factor 1, subunit A (p150), PCNA,
RuvB12, and others (Table 1). A number of genes involved
in spindle formation and chromosome segregation, includ-
ing kinesin family member C1 (Kifc1), stathmin, tubulin
beta 5 (Tubb5), transforming acidic coiled-coil containing
protein 3 (Tacc3) were enriched in NS. Restriction of Tk1,
HMG2, and PCNA expression to the germinal zone was
confirmed by in situ experiments (Table 2; Fig. 2B). Tk1 is
involved in DNA replication and is activated at late G1 of
the cell cycle. The expression of Tk1 was thought to be
controlled at the level of posttranscription and translation
(Stewart et al., 1987; Coppock and Pardee, 1987; Sherley
and Kelly, 1988; Gudas et al., 1988). In situ hybridization in
Fig. 2B shows that Tk1 mRNA expression is restricted
within the germinal zone to the superficial ventricular zone
(VZ) and is absent from the periventricular deeper VZ. This
is consistent with the interkinetic nuclear migration of neu-
ral precursors occurring at this time in the germinal zone, in
which cells undergoing late G1 have ascended to the VZ/IZ
(intermediate zone) border away from the ventricle (Sauer
and Walker, 1959).
Metabolism
Genes in several metabolic pathways showed a specific
pattern of enrichment in NS. Out of 108 genes on the array
known to be involved in intermediary metabolism and com-
prising 74 different metabolic pathways, only 19 (17.6%)
genes were differentially expressed. In total, 18 genes en-
riched in NS and 1 downregulated in NS were placed in
known metabolic pathways by using the KEGG database
(http://www.genome.ad.jp/kegg/) (Table 3). Metabolic
genes enriched in NS were involved in 19 different path-
ways. Only 1 gene downregulated in NS, carnitine palmi-
toyltransferase 1 (Cpt1a), was involved in the metabolism of
fatty acids and glycerolipids; most genes involved in fatty
acid metabolism were upregulated in NS. Genes from spe-
cific biochemical pathways that showed significant enrich-
ment in NS were determined by comparison of the percent-
age of genes altered in expression in a particular
biochemical pathway to the overall percentage of change in
metabolic genes during the differentiation program (Table
3). Glycolysis and gluconeogenesis pathways showed the
highest alterations of expression (P  0.01; 2). Some
NS-enriched genes (acetyl-Coenzyme A synthetase 1, ci-
trate synthase, - enolase, glucose phosphate isomerase 1,
and pyruvate dehydrogenase) are utilized in several differ-
ent metabolic pathways. Acetyl-Coenzyme A synthetase 1
plays a major role in both carbohydrate and energy metab-
olism. Pyruvate dehydrogenase and -enolase are involved
in both carbohydrate and amino acid metabolism. Although
changes in metabolic pathways are quite specific and not
broad, many of the metabolic genes identified as NS-en-
riched could be related to the simple metabolic demands of
increased cell division. However, the absence of many of
these other changes in other proliferating cells in culture
Table 3
Placement of NS and DC enriched genes into metabolic pathways
according to the KEGG database
Metabolic pathwaya Totalb NSc DCd
Carbohydrate Metabolism
Citrate cycle (TCA cycle) 6 3 —
Glycolysis/Gluconeogenesis 6 4 —
Pentose phosphate pathway 2 1 —
Galactose metabolism 4 1 —
Pyruvate metabolism 5 2 —
Glyoxylate and dicarboxylate metabolism 5 1 —
Propanoate metabolism 5 1 —
Butanoate metabolism 5 1 —
Energy metabolism
Reductive carboxylate cycle (CO2 fixation) 3 1 —
Nitrogen metabolism 2 1 —
Nucleotide metabolism
Purine metabolism 7 1 —
Pyrimidine metabolism 6 2 —
Amino acid metabolism
Valine, leucine, and isoleucine biosynthesis
and degradation
2 2 —
Phenylalanine, tyrosine, and tryptophan
biosynthesis
1 1 —
Urea cycle and metabolism of amino
groups
2 1 —
Metabolism of complex carbohydrates
Starch and sucrose metabolism 2 2 —
N-Glycans biosynthesis 3 1 —
Metabolism of cofactors and vitamines
Pantothenate and CoA biosynthesis 1 1 —
One carbon pool by folate 4 1 —
Lipid metabolism
Fatty acid and glycerolipid metabolism 5 — 1
Note. a Metabolic pathways altered in the course of differentiation.
b Total number of array genes involved in the particular metabolic
pathway.
c,d Number of NS and DC genes, respectively, altered in a particular
metabolic pathway.
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(Zhao et al., 2002) suggests that at least a subset of these
metabolic pathways play specific, as yet unknown roles in
neural progenitor proliferation.
We further investigated the extent to which genes iden-
tified in NSC cultures overlapped with recent studies char-
acterizing general stem cell or neural progenitor genes
(Ivanova et al., 2002; Ramalho-Santos et al., 2002; Zhao et
al., 2002). Elucidation of common genetic factors identified
in various stem cell populations is complicated by different
experimental designs and analytic approaches. Most genes
identified in any of the microarray studies cited do not
overlap with each other or the list of genes identified in this
study. This likely reflects differences in experimental design
and progenitor populations studied and further suggests that
gene expression in distinct stem cell populations is more
different than similar. Nevertheless, some NS-specific genes
identified in our study were also identified either in studies
of neural stem cells and neural progenitors (Ivanova et al.,
2002; Ramalho-Santos et al., 2002), proliferating granule
cell precursors (Zhao et al., 2002), or the neural tube at early
stages (Luo et al., 2002). Strikingly, the majority of these
overlap genes are involved in DNA replication and cell
cycle control. For example, a number of cell cycle-depen-
dent genes enriched in NS, such as c-Myc, cyclin D2,
PCNA, Tk1, and Cnbp, were also enriched in hematopoietic
cells, possibly reflecting the common mechanisms of self-
renewal, which are likely to be shared by other stem cell
populations (http://stemcell.princeton.edu/SCDB update/in-
dex.html).
Discussion
The commitment of NSC to self-renewal, differentiation,
or death presumably depends on the number of extrinsic and
intrinsic factors triggering various signaling pathways
(McKay, 1997; Rao, 1999). Rather than gene-by-gene
study, we used cDNA microarray analysis to identify more
global gene expression patterns associated with neural stem
cell homeostasis. Here, genes identified as enriched in NSC
cultures in vitro were followed up in vivo by using in situ
hybridization, demonstrating germinal zone expression for
many of the identified NS-enriched genes. The hypothetical
network of cell-cycle regulatory components of neural pro-
genitors, based on microarray analysis and the existing
literature, provides a number of likely connections between
cell-cycle regulation and specific signaling and metabolic
pathways in neural progenitors (Fig. 5).
In situ hybridization permits in vivo confirmation of gene
expression patterns
Neurosphere cultures, as documented in this study, are
heterogeneous, containing neural stem cells and other cells
at various stages of differentiation. In our previous study,
we demonstrated that the NS cultures contain approximately
10-fold greater numbers of tripotent neural stem cells than
the DC condiditon (Geschwind et al., 2001). Here, we
demonstrated that the NS cultures contain significantly
more differentiated cells after 24 h of growth factor with-
drawal. It is likely that immunostaining underestimates the
numbers of cells that are committed to a more mature state
at this period, as changes in transcription factor and other
gene expression would be expected to precede the changes
in markers of terminal differentiation. Thus, it is likely that
our comparison of NS and DC truly reflects differences in
gene expression between stem cells/early neural progenitors
and more committed, differentiated cells.
Expression patterns of genes with high expression in the
germinal zones imply their possible associations with neural
progenitors and CNS development. Most of the investigated
genes show distinct expression patterns in the periventricu-
lar germinal zones, the VZ and SVZ, that are consistent with
neuro- or gliogenesis (Sox3, FABP7, Tk1; Fig. 2). It must
be noted that a number of genes were expressed within other
brain regions, in addition to their expression in germinal
zones. It is unknown whether this nongerminal zone pattern
is due to a continued expression in cells as they proceed
from a stem or progenitor cell to a differentiated cell, or to
a reexpression of the gene in differentiated cells. Addition-
ally, there are genes enriched in DC with high germinal
zone expression levels (e.g., Nfatc2 and Smoh) (Fig. 3B).
This is not surprising, since the cells were only differenti-
ated for 24 h, which would leave many of the cells in the
early stages of differentiation rather than in the final differ-
entiated state. Cells exiting the cell cycle in the neuroepi-
thelium may express these genes, such as Smoh, which are
involved in cell fate decisions and interact with key ele-
ments of cell cycle control (Rowitch et al., 2002; Fig. 5 and
below).
Rb in NSC cell-cycle regulation
We used common standards based on The Gene Ontol-
ogy Consortium classification (http://www.geneontology.
org/) and the Source database (http://source.stanford.edu) to
categorize genes according to their involvement in a specific
biological process (Table 1; Fig. 4). The pattern of cell
cycle-related genes led us to the hypothesis that the retino-
blastoma protein complex (pRb) pathway may play an im-
portant role in neural stem cell proliferation (Fig. 5). The
pRB complex regulates cellular proliferation and differen-
tiation (for review, see Yoshikawa, 2000), but its role in the
control of neural progenitor proliferation was previously
unappreciated. Consistent with the hypothesis of pRb com-
plex inhibition (for review, see Ferguson and Slack, 2001),
we observed an increase in a number of E2F target genes
reported previously, including cyclin D1 and D2, minichro-
mosome maintenance deficient proteins 2, 4, 6, and 7, cdc2,
retinol binding protein 1, and c-Myc (Fig. 5).
In addition to positive regulation by E2F factors (Muller
et al., 1994), cyclin D1 and D2 expression is activated by
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c-Myc and Ect2 (epithelial cell transforming sequence 2)
protooncogenes (Westwick et al., 1998; Leone et al., 2001).
NSC-specific regulation of c-Myc might be achieved
through the positive action of the putative transcriptional
activator PTTG1 (pituitary tumor-transforming gene) and
zinc-finger protein CNBP1 (cellular retroviral nucleic acid
binding protein 1) (Michelotti et al., 1995; Pei, 2001), both
of which were enriched in NS. Supportive of this model is
the recent demonstration of a CNBP-specific role in fore-
brain development as a CNS-specific positive regulator of
c-Myc, controlling NSC proliferation at the levels of G1/S
and G2/M transition (Chen et al., 2003). Additionally,
PTTG1 is known to stimulate bFGF expression (Faglia and
Spada, 2001) and is coregulated with cyclin B1 (Zou et al.,
1999).
Factors regulating the Cdk1, cyclinB1, and cdc2 protein
complex are expressed by proliferating neural progenitors
Another cell cycle complex involved in the regulation of
neural progenitor proliferation is the CyclinB1/cdk1/cdc2
complex. Cyclin B1 is an activator of cyclin-dependent
kinase 1 (p34; cdc2), and both proteins work in a complex
that plays a key role in progression from G2 to the M phase
of the cell cycle (Elledge, 1996; O’Connor, 1997). Expres-
sion of cdc2 is responsible for controlling the transition
from G1 phase to the S phase and from the G2 phase to the
M phase of the cell cycle, and it has been shown to be
enriched in neuronal precursors (Hayes et al., 1991). The
function of Cks1, also enriched in NS, is not clearly under-
stood, although it is known that it binds to cdc2, and pos-
sibly both proteins work in cooperation.
The signal inducing cyclin B1 in neural progenitors is
possibly FoxM1, a winged helix factor found in the prolif-
erating cells of various tissues (Yao et al., 1997) that was
upregulated in NS. Transient reporter assays have demon-
strated that FoxM1 activates cyclin B1 (Leung et al., 2001).
The specific germinal zone expression pattern of FoxM1
supports its specific role in NSC biogenesis, possibly via a
direct effect on cyclin B1, which inhibits differentiation
(Fig. 3A). Gadd45b, upregulated in NS, also interacts with
the cyclin B1/cdc2 complex. Gadd45b is a member of a
family of evolutionarily conserved, small, acidic, nuclear
proteins, that has been demonstrated to specifically interact
with and inhibit the kinase activity of the Cdc2/CyclinB1
complex (Vairapandi et al., 2002; Fig. 5). Thus, inhibition
by Gadd45b results in the G2/M cell-cycle arrest and sub-
sequent differentiation. Another inhibitor of cell prolifera-
tion is a nuclear factor of activated T cells (Nfatc2) previ-
ously shown to be an inhibitor of Cdk4 expression (Baksh et
al., 2002; Caetano et al., 2002). This gene, originally iden-
tified in hematopoesis and now shown to be expressed in
NSC, provides another example of a gene enriched in mul-
tiple progenitor or stem cell populations, similar to stem cell
overlap genes identified by us and others (Geschwind et al.,
2001; Terskikh et al., 2001; Ivanova et al., 2002; Ramalho-
Santos et al., 2002).
Cell cycle coupling to cell fate: roles of wnt, shh, and
notch signal transduction pathways
Several genes previously implicated in neurogenesis or
neural stem cell fate were found in the course of this study.
Expression of combinations of transcription factors deter-
mines the fate of pools of pluripotent cells in the developing
embryo (Rowitch et al., 2002). Two main classes of tran-
scription factors are known to determine neuronal and glial
fate, the homeodomain factors and the basic helix–loop–
helix (HLH) family of transcription factors (Zhou et al.,
2000, 2001; Sun et al., 2001). One of the HLH family
members known to be critical in neural development is
Olig2, as its expression clearly defines the cells that mature
into oligodendrocytes and motor neurons (Zhou and Ander-
son, 2002). In our experiments, Olig2 is significantly up-
regulated in NS, consistent with its role in progenitor cell
fate (Fig. 3; Takebayashi et al., 2000).
One of the most interesting transcription factors identi-
fied, Sox3, was enriched in NS, consistent with previous
data showing this gene to be enriched in chick neuroepithe-
lium (Uwanogho et al., 1995). Other members of the Sox
(Sry-related HMG box-containing) family of transcription
factors play an important role in neurogenesis (Cai et al.,
2002). The Drosophila Sox3 homologue is essential for
neural progenitor formation (Buescher et al., 2002), and loss
of Sox3 expression precedes neuronal differentiation in ep-
ithelial structures. These data, coupled with the current
microarray and in situ data in mouse, suggest that Sox3
might be involved in the preservation of a proliferating
neural progenitor pool in the mammalian brain. Sox3 binds
to - catenin, inhibiting the Wnt signal in Xenopus (Zorn et
al., 1999), which activates important growth regulatory
genes, including cyclin D1 (Shtutman et al., 1999) and
c-Myc (He et al., 1998). The recent demonstration that
-catenin is highly expressed in mammalian neural precur-
sors and influences their cell fate choice by cell cycle
reentry rather than allowing them to differentiate is intrigu-
ing in this regard (Chenn and Walsh, 2002). The evidence
that Sox3 inhibits -catenin (Zorn et al., 1999), taken to-
gether with our data, suggests a mechanism by which Sox3
can modulate the Wnt signaling pathway, providing another
connection between the cell cycle and cell fate determina-
tion via influencing the decision of neural precursor to
further divide or differentiate.
Smoothened homologue (Smoh) may represent another
link between proliferation and differentiation of neural and
glial progenitors (Kenney and Rowitch, 2000; Rowitch et
al., 2002; Zhao et al., 2002). Smoothened (Smoh) is a
putative transmembrane signaling component of the sonic
hedgehog (Shh)–receptor complex required for activation of
a SHH pathway (Ingham, 1998; Ingham and McMahon,
2001) and was upregulated in DC cultures. Both Gli1 and
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Gli2, which are downstream of Smoh, and Shh are ex-
pressed in NS and DC cultures (RT-PCR; data not shown),
supporting the notion that the Shh pathway is active in
progenitor cultures. However, delineation of the precise role
of Shh signaling requires further investigation. Both Wnt
and Hedgehog signaling pathways have long been known to
regulate growth and patterning during embryonic develop-
ment. Our data could further suggest the presence of fine-
tuning combinatiorial mechanisms of Wnt and Shh path-
ways regulating neural and glial stem-cell/progenitor’s
decision for reentering the cell cycle or terminal differenti-
ation.
Notch signaling plays a critical role in cell fate determi-
nation and is reported to both inhibit a neuronal fate as well
as promote a glial fate (Morrison et al., 2000). Genes reg-
ulating the Notch pathway identified were Presenilin 2 and
Nicastrin (Struhl and Adachi, 2000). Presenilins, along with
Notch, are known to be enriched in the periventricular
germinal zones during brain development (Lindsell et al.,
1996; Irvin et al., 2001) (Fig. 3A). Expression of Nicastrin,
a gene representing an integral component of the high mo-
lecular weight presenilin complex, was previously not as-
sociated with the germinal zone or NSC cultures. This study
suggests a previously unidentified role for this gene in
cerebral cortical development. It is interesting to note that,
despite their presence on the array, members of the Notch
receptor family were not identified in this study. This is
possibly due to the ample expression of these receptors in
differentiated cells as well as in progenitors (Irvin et al.,
2001).
Metabolic profile of proliferating neurospheres
Glucose metabolism
Neural stem cells possess the potential for proliferation,
differentiation, self- renewal, and quiescence, and each of
these states is likely associated with a specific metabolic
phenotype, characterized by the production of both energy
and special substrates necessary for the cells to function in
that particular situation. Previous studies indicate that glu-
cose carbon redistribution between major metabolic path-
ways plays a critical role in cell proliferation (e.g., Boros et
al., 2002).
Several links between cell cycle control and specific
metabolic pathways were identified. Activation of down-
stream E2F-like gene targets results in a high rate of glucose
utilization and macromolecule synthesis. NS cultures were
clearly associated with the activation of metabolic enzymes
that increase glucose carbon utilization for anabolic pur-
poses, such as purine and pyrimidine synthesis (Table 3).
Proliferating cells are highly dependent on de novo synthe-
sis of purines and pyrimidines, as well as ribose for nucleic
acid synthesis, which is produced from glucose, and genes
from both of these pathways are upregulated in NS in this
study. These processes in turn become highly dependent on
the availability of glucose carbons and increased activity of
glycolytic, pentose (glucose phosphate isomerase 1 com-
plex), galactose (galactokinase), and TCA cycle enzymes
(citrate synthase, ATP citrate lyase, isocitrate dehydroge-
nase 3 (NAD) alpha) (Table 3). c-Myc is required for the
glucose-mediated induction of metabolic enzyme genes
(Collier et al., 2002), directly transactivating enolase and
increasing glucose uptake (Osthus et al., 2000), providing
another direct link between the cell cycle related changes
and NS metabolism observed in this study.
Fatty acid metabolism
Several genes involved in lipid uptake and metabolism
were enriched in NS, including CNBP, VLDLR, FABP7,
and SRB1, all involved in cholesterol metabolism or lipid
biosynthesis. In addition to their involvement in neuronal
migration (Feng et al., 1994; Trommsdorff et al., 1999),
several of the genes in this class of lipid binding or lipid
metabolism may also play more basic roles in progenitor
homeostasis (Fukasawa et al., 1996). A general downregu-
lation of genes with a role in lipid and cholesterol synthesis
during differentiation reflects the reduced need for new
membrane synthesis after the cessation of cell division.
In conclusion, it is clear that a combinatorial network of
various signaling pathways underlies the biogenesis of neu-
ral progenitors. Here, we demonstrate the utility of large-
scale monitoring of gene expression for identifying major
regulatory processes in neural stem cell cultures and in
generating hypotheses that can be tested in subsequent stud-
ies. These findings further emphasize the critical role of the
cell cycle and its coupling to cell fate decisions during
neural stem cell proliferation and self-renewal, as well as
the early steps of differentiation in the mammalian cerebral
cortex.
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